175 related articles for article (PubMed ID: 26352195)
1. Murine Cyp3a knockout chimeric mice with humanized liver: prediction of the metabolic profile of nefazodone in humans.
Nakada N; Kawamura A; Kamimura H; Sato K; Kazuki Y; Kakuni M; Ohbuchi M; Kato K; Tateno C; Oshimura M; Usui T
Biopharm Drug Dispos; 2016 Jan; 37(1):3-14. PubMed ID: 26352195
[TBL] [Abstract][Full Text] [Related]
2. Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver.
Kato K; Ohbuchi M; Hamamura S; Ohshita H; Kazuki Y; Oshimura M; Sato K; Nakada N; Kawamura A; Usui T; Kamimura H; Tateno C
Drug Metab Dispos; 2015 Aug; 43(8):1208-17. PubMed ID: 25979261
[TBL] [Abstract][Full Text] [Related]
3. Human CYP3A4 and the metabolism of nefazodone and hydroxynefazodone by human liver microsomes and heterologously expressed enzymes.
Rotzinger S; Baker GB
Eur Neuropsychopharmacol; 2002 Apr; 12(2):91-100. PubMed ID: 11872324
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the hepatic metabolism of triazolam in wild-type andCyp3a-knockout mice for understanding CYP3A-mediated metabolism inCYP3A-humanised mice
Minegishi G; Kazuki Y; Yamasaki Y; Okuya F; Akita H; Oshimura M; Kobayashi K
Xenobiotica; 2019 Nov; 49(11):1303-1310. PubMed ID: 30561249
[TBL] [Abstract][Full Text] [Related]
5. Predictability of metabolism of ibuprofen and naproxen using chimeric mice with human hepatocytes.
Sanoh S; Horiguchi A; Sugihara K; Kotake Y; Tayama Y; Uramaru N; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
Drug Metab Dispos; 2012 Dec; 40(12):2267-72. PubMed ID: 22936315
[TBL] [Abstract][Full Text] [Related]
6. Prediction of in vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver.
Sanoh S; Horiguchi A; Sugihara K; Kotake Y; Tayama Y; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
Drug Metab Dispos; 2012 Feb; 40(2):322-8. PubMed ID: 22048522
[TBL] [Abstract][Full Text] [Related]
7. Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions.
von Moltke LL; Greenblatt DJ; Granda BW; Grassi JM; Schmider J; Harmatz JS; Shader RI
Psychopharmacology (Berl); 1999 Jul; 145(1):113-22. PubMed ID: 10445380
[TBL] [Abstract][Full Text] [Related]
8. Prediction of human metabolism of the sedative-hypnotic zaleplon using chimeric mice transplanted with human hepatocytes.
Tanoue C; Sugihara K; Uramaru N; Tayama Y; Watanabe Y; Horie T; Ohta S; Kitamura S
Xenobiotica; 2013 Nov; 43(11):956-62. PubMed ID: 23651075
[TBL] [Abstract][Full Text] [Related]
9. Drug-drug interactions and metabolism in cytochrome P450 2C knockout mice: application to troleandomycin and midazolam.
Grimsley A; Gallagher R; Hutchison M; Pickup K; Wilson ID; Samuelsson K
Biochem Pharmacol; 2013 Aug; 86(4):529-38. PubMed ID: 23732297
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma.
Mayol RF; Cole CA; Luke GM; Colson KL; Kerns EH
Drug Metab Dispos; 1994; 22(2):304-11. PubMed ID: 8013286
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in humans.
Barbhaiya RH; Dandekar KA; Greene DS
Drug Metab Dispos; 1996 Jan; 24(1):91-5. PubMed ID: 8825195
[TBL] [Abstract][Full Text] [Related]
12. Prediction of human metabolism of FK3453 by aldehyde oxidase using chimeric mice transplanted with human or rat hepatocytes.
Sanoh S; Nozaki K; Murai H; Terashita S; Teramura T; Ohta S
Drug Metab Dispos; 2012 Jan; 40(1):76-82. PubMed ID: 21984595
[TBL] [Abstract][Full Text] [Related]
13. Nefazodone pharmacokinetics: assessment of nonlinearity, intra-subject variability and time to attain steady-state plasma concentrations after dose escalation and de-escalation.
Barbhaiya RH; Shukla UA; Chaikin P; Greene DS; Marathe PH
Eur J Clin Pharmacol; 1996; 50(1-2):101-7. PubMed ID: 8739819
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cytochrome P450 by nefazodone in vitro: studies of dextromethorphan O- and N-demethylation.
Schmider J; Greenblatt DJ; von Moltke LL; Harmatz JS; Shader RI
Br J Clin Pharmacol; 1996 Apr; 41(4):339-43. PubMed ID: 8730981
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Utility of Chimeric Mice with Humanized Livers for the Characterization and Profiling of the Metabolites of a Selective Inhibitor (YM543) of the Sodium-Glucose Cotransporter 2.
Nakada N
Pharm Res; 2017 Apr; 34(4):874-886. PubMed ID: 28194636
[TBL] [Abstract][Full Text] [Related]
16. Midazolam metabolism in cytochrome P450 3A knockout mice can be attributed to up-regulated CYP2C enzymes.
van Waterschoot RA; van Herwaarden AE; Lagas JS; Sparidans RW; Wagenaar E; van der Kruijssen CM; Goldstein JA; Zeldin DC; Beijnen JH; Schinkel AH
Mol Pharmacol; 2008 Mar; 73(3):1029-36. PubMed ID: 18156313
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein, multidrug-resistance associated protein 2, Cyp3a, and carboxylesterase affect the oral availability and metabolism of vinorelbine.
Lagas JS; Damen CW; van Waterschoot RA; Iusuf D; Beijnen JH; Schinkel AH
Mol Pharmacol; 2012 Oct; 82(4):636-44. PubMed ID: 22767610
[TBL] [Abstract][Full Text] [Related]
18. Investigation of drug-drug interactions caused by human pregnane X receptor-mediated induction of CYP3A4 and CYP2C subfamilies in chimeric mice with a humanized liver.
Hasegawa M; Tahara H; Inoue R; Kakuni M; Tateno C; Ushiki J
Drug Metab Dispos; 2012 Mar; 40(3):474-80. PubMed ID: 22126990
[TBL] [Abstract][Full Text] [Related]
19. Validation of uPA/SCID mouse with humanized liver as a human liver model: protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases by LC-MS/MS.
Ohtsuki S; Kawakami H; Inoue T; Nakamura K; Tateno C; Katsukura Y; Obuchi W; Uchida Y; Kamiie J; Horie T; Terasaki T
Drug Metab Dispos; 2014 Jun; 42(6):1039-43. PubMed ID: 24711249
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Human Disproportionate and Biliary Excreted Metabolites Using Chimeric Mice with Humanized Liver.
Kato S; Shah A; Plesescu M; Miyata Y; Bolleddula J; Chowdhury S; Zhu X
Drug Metab Dispos; 2020 Oct; 48(10):934-943. PubMed ID: 32665417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
